• Image for When the world needs us, together we rise to the challenge
  • Image for Accelerating global access
  • Image for How we’re prioritizing supply
  • Image for An oral history: Stepping up throughout the COVID-19 pandemic
Next story:
Responsibility When the world needs us, together we rise to the challenge

Read more

Responsibility Accelerating global access

Learn more

Responsibility How we’re prioritizing supply

Read more

Responsibility An oral history: Stepping up throughout the COVID-19 pandemic

Read more

Next
  • Image for When the world needs us, together we rise to the challenge
  • Image for Accelerating global access
  • Image for How we’re prioritizing supply
  • Image for An oral history: Stepping up throughout the COVID-19 pandemic

We invent for life

We’re following the science to tackle some of the world’s greatest health threats. But don’t take it from us – see what our people and patients say.

Image for Colleagues ensure timely supply of our investigational oral antiviral COVID-19 medicine
Innovation

Colleagues ensure timely supply of our investigational oral antiviral COVID-19 medicine

Get a behind-the-scenes look at Haarlem, Netherlands, where some of our first doses are being produced and packaged
Image for All hands on deck against COVID-19
Innovation

All hands on deck against COVID-19

How every division at Merck is pitching in to address a global need
young blonde girl with mom in doctors office
Patients & caregivers

How can we support you?

Medical treatment can be stressful enough. If you can’t afford your prescribed medications, we may be able to help you.

Research & products

Where creativity meets research

We bring creative minds together to invent important medicines and vaccines. We stop at nothing to help save and improve lives.

Column one image
Corporate responsibility

Supporting the future of our business and the well-being of patients, people and communities around the world.

Column one image
Investor relations

Find our latest financials, events & presentations, news, stock information and investor contacts.